Biologics Facility Design & Pharmaceutical Regulatory Aspects

  • Check with publisher
  • Published date: February 21, 2017
    • Fremont, California, United States

Overview:
This course explores some of the best practices of pharmaceutical facility design with an emphasis on regulatory aspects. FDA and other global regulatory body requirements are discussed and the reasoning behind them.

Why should you Attend:
The attendee will learn what is important in facility design from the FDA and regulatory standpoint. The attendee will understand what FDA looks for during a facility inspection. The attendee will be able to minimize possible design errors which are difficult and expensive to fix post-build. The attendee will understand what FDA looks for in reviewing the facility design and the flow patterns.

Areas Covered in the Session:
Best design practices for Pharma facilities
Best design practices for biologics facilities
Regulatory compliance for Pharma and biologics facilities design
Flow patterns and cross contamination controls

Who Will Benefit:
Compliance Manager
Facility Manager
Validation Manager
Regulatory Manager
Design Team/Architects

Speaker Profile:
John R. Godshalk currently works for the Biologics Consulting Group as a Senior Consultant. John served as a Senior Review Biochemical Engineer and Lead cGMP inspector in the Division of Manufacturing and Product Quality at CBER, FDA. He contributed to formulation of FDA policy.

Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support@compliance4All.com

Result 0 votes
Compliance4All
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Computer Systems Validation Conference 2018 - 21 CFR Part11 Compliance

    Computer Systems Validation Conference 2018 - 21 CFR Part11 Compliance

    Pharmacology - Drug Development Zurich (Zurich) April 2, 2018 Check with publisher

    Course "Validation and 21 CFR Part 11 Compliance of Computer Systems" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. Overview: Computer Systems Validation (CSV) also kn...

  • New EU Medical Device Regulation | Updated Regulation 2018

    New EU Medical Device Regulation | Updated Regulation 2018

    Pharmacology - Drug Development Zurich (Zurich) April 2, 2018 Check with publisher

    Course "The New EU Medical Device regulation" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. Overview: Regulation proposals of the European Commission Background In 201...

  • Clinical Data Management - Benefits of Standardization in Establishing CDM Processes

    Clinical Data Management - Benefits of Standardization in Establishing CDM Processes

    Pharmacology - Drug Development Philadelphia (pennsylvania) April 2, 2018 Check with publisher

    Course "Clinical Data Management" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. Overview: When new drugs or devices are tested in humans, the data generated by, and re...